When Science Moves Mountains
Dana-Farber Research Shows Promise for Targeted Therapies for Pediatric Gliomas
U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nation’s Best for 2025-2026
Study Paves Path to Improved Diagnosis, Treatment of NUT Carcinoma
Global Rise in Many Early-Onset GI Cancers Detailed in Two Dana-Farber Reviews, With Colorectal Cancer Leading the Trend
TILs: What Are They and How Are They Used in Cancer Treatment?
Modified Personalized Cancer Vaccine Generates Powerful Immune Response
Teen with Rare Sarcoma Enjoys Stellar Response on Clinical Trial
Dana-Farber Report Shows Alarming Rise in Many Gastrointestinal Cancers in Young People
Tracing a Career of Unrelenting Discovery
Novel Cancer Screening Test for Veterans Now Being Offered at Dana-Farber Cancer Institute
Cell Density Speaks Volumes About Cancer Treatment Choices
FDA Approves Immune Checkpoint Inhibitor Drug for Patients With Resectable Locally Advanced Head and Neck Cancer
Double Negative in Cells Could Undermine PARP Inhibitors
The Angeles Clinic and Research Institute
Showing 46 - 60 of 987 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...66 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
